UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide, Bortezomib and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Subjects…
    Sarah Holstein
  2. A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Effect of Vandetanib on Cellular Markers of Proliferation and Apoptosis in Invasive Breast Cancer
    Ronald Weigel
  3. Phase 1b, Open-label, Multicenter Study of Urelumab (BMS-663513) in Combination with Rituximab in Subjects with Relapsed/Refractory B-Cell Malignancies
    Brian Link
  4. A phase II randomized, multicenter study of treatment-free remission in chronic myeloid leukemia in chronic phase (CML-CP) patients who achieve and sustain MR4.5 after switching to nilotinib
    Thomas Carter
  5. A Phase III, Multicenter, Double-Blind, Randomized, Placebo- Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in…
    Eva Tsalikian
  6. A Randomized Phase II Study Comparing Two Different Conditioning Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Children with Juvenile Myelomonocytic Leukemia (JMML)
    Ayman El-Sheikh
  7. SynCardia Freedom Driver System Study
    Jennifer Goerbig-Campbell
  8. Study to Demonstrate Long-Term Safety and Efficacy of Vagus Nerve Stimulation
    Frances Johnson
  9. A phase III, multicenter, randomized, open-label study of oral LDK378 versus standard chemotherapy in adult patients with ALK-rearranged (ALK-positive) advanced non-small cell lung cancer who have bee…
    Taher Abu Hejleh
  10. A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer
    Taher Abu Hejleh
  11. A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
    Brian Link
  12. Phase 2 study of the mTOR inhibitor everolimus in combination with bevacizumab in patients with spor(1)
    Mohammed Milhem
  13. Randomized Phase II Study of AB (Abraxane, Bevacizumab) versus Ipilimumab for 1st Line Therapy of Unresectable Stage IV Metastatic Malignant Melanoma (BRAF V600E Negative)
    Mohammed Milhem
  14. Association Between Exercise and Centrally-Mediated Pain Perception
    Laura Frey-Law
  15. Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center Randomized Controlled Study Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections with End
    Benjamin Miller MD
  16. Phase III trial of enzalutamide (NSC # 766085) versus enzalutamide, abiraterone and prednisone for c(1)
    Daniel Vaena
  17. Comparator Study of 68Ga-DOTATOC PET/CT with Octreoscan + high-resolution, contrast-enhanced CT for diagnosis and staging in neuroendocrine tumors and other somatostatin receptor positive tumors
    M. Sue O'Dorisio
  18. Single Autologous Transplant Followed by Consolidation and Maintenance for Participants Diagnosed with Multiple Myeloma or a Related Plasma Cell Malignancy
    Guido Tricot
  19. Rituximab Therapy and Cellular Immune Response (150)
    George Weiner
  20. A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma
    Guido Tricot

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.